Davies Robert, Wales Andrew
Bacteriology and Food Safety Dept., Animal and Plant Health Agency (APHA - Weybridge), Woodham Lane, New Haw, Addlestone, KT15 3NB, UK.
Pathology and Infectious Diseases Dept., School of Veterinary Medicine, Faculty of Health and Medical Sciences, Vet School Main Building, Daphne Jackson Rd., Univ. of Surrey, Guildford, GU2 7AL, UK.
Compr Rev Food Sci Food Saf. 2019 May;18(3):753-774. doi: 10.1111/1541-4337.12438. Epub 2019 Apr 17.
Resistance to therapeutic antimicrobial agents is recognized as a growing problem for both human and veterinary medicine, and the need to address the issue in both of these linked domains is a current priority in public policy. Efforts to limit antimicrobial resistance (AMR) on farms have so far focused on control of the supply and use of antimicrobial drugs, plus husbandry measures to reduce infectious disease. In the United Kingdom and some other countries, substantial progress has been made recently against targets on agricultural antimicrobial drug use. However, evidence suggests that resistant pathogenic and commensal bacteria can persist and spread within and between premises despite declining or zero antimicrobial drug use. Reasons for this are likely complex and varied but may include: bacterial adaptations to ameliorate fitness costs associated with maintenance and replication of resistance genes and associated proteins, horizontal transmission of genetic resistance determinants between bacteria, physical transfer of bacteria via movement (of animals, workers, and equipment), ineffective cleaning and disinfection, and co-selection of resistance to certain drugs by use of other antimicrobials, heavy metals, or biocides. Areas of particular concern for public health include extended-spectrum cephalosporinases and fluoroquinolone resistance among Enterobacteriaceae, livestock-associated methicillin-resistant Staphylococcus aureus, and the emergence of transmissible colistin resistance. Aspects of biosecurity have repeatedly been identified as risk factors for the presence of AMR on farm premises, but there are large gaps in our understanding of the most important risk factors and the most effective interventions. The present review aims to summarize the present state of knowledge in this area, from a European perspective.
治疗性抗菌药物耐药性被认为是人类医学和兽医学中日益严重的问题,在这两个相关领域解决该问题是当前公共政策的优先事项。迄今为止,限制农场抗菌药物耐药性(AMR)的努力主要集中在控制抗菌药物的供应和使用,以及采取饲养管理措施以减少传染病。在英国和其他一些国家,最近在实现农业抗菌药物使用目标方面取得了重大进展。然而,有证据表明,尽管抗菌药物使用量下降或为零,但耐药病原菌和共生菌仍可在养殖场内及之间持续存在和传播。其原因可能复杂多样,包括:细菌为降低与耐药基因及相关蛋白质的维持和复制相关的适应性成本而发生的适应性变化、细菌间耐药基因决定簇的水平转移、细菌通过(动物、工人和设备的)移动进行的物理转移、清洁和消毒无效,以及使用其他抗菌药物、重金属或杀菌剂导致对某些药物耐药性的共同选择。公共卫生特别关注的领域包括肠杆菌科细菌中的超广谱头孢菌素酶和氟喹诺酮耐药性、与家畜相关的耐甲氧西林金黄色葡萄球菌,以及可传播的黏菌素耐药性的出现。生物安全方面一再被确定为养殖场存在AMR的风险因素,但我们对最重要的风险因素和最有效的干预措施的理解存在很大差距。本综述旨在从欧洲视角总结该领域的现有知识状况。